Journal of Virus Eradication (Apr 2019)

What risk of death would people take to be cured of HIV and why? A survey of people living with HIV

  • Benjamin R. Murray,
  • Allison Kratka,
  • Karen A. Scherr,
  • Nir Eyal,
  • Jennifer Blumenthal-Barby,
  • Kenneth A. Freedberg,
  • Daniel R. Kuritzkes,
  • James K. Hammitt,
  • Regina Edifor,
  • Madelaine N. Katz,
  • Kathryn I. Pollak,
  • Brian J. Zikmund-Fisher,
  • Scott D. Halpern,
  • Mary C. Barks,
  • Peter A. Ubel

Journal volume & issue
Vol. 5, no. 2
pp. 109 – 115

Abstract

Read online

People living with HIV (PLWHIV) can reasonably expect near-normal longevity, yet many express a willingness to assume significant risks to be cured. We surveyed 200 PLWHIV who were stable on antiretroviral therapy (ART) to quantify associations between the benefits they anticipate from a cure and their risk tolerance for curative treatments. Sixty-five per cent expected their health to improve if cured of HIV, 41% predicted the virus would stop responding to medications over the next 20 years and 54% predicted experiencing serious medication side effects in the next 20 years. Respondents’ willingness to risk death for a cure varied widely (median 10%, 75th percentile 50%). In multivariate analyses, willingness to risk death was associated with expected long-term side effects of ART, greater financial resources and being employed (all P < 0.05) but was not associated with perceptions of how their health would improve if cured.

Keywords